Total Payments
$18,620
2024 Payments
$350.77
Companies
36
Transactions
1,127
Medicare Patients
4,258
Medicare Billing
$713,896
Payment Breakdown by Category
Food & Beverage$18,353 (98.6%)
Travel$266.96 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,353 | 1,124 | 98.6% |
| Travel and Lodging | $266.96 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $14,287 | 888 | $0 (2024) |
| Boston Scientific Corporation | $757.45 | 9 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $392.63 | 25 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $335.17 | 29 | $0 (2021) |
| PFIZER INC. | $328.99 | 17 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $261.09 | 17 | $0 (2021) |
| ABBVIE INC. | $251.59 | 16 | $0 (2024) |
| Zyla Life Sciences, Inc. | $246.16 | 28 | $0 (2020) |
| Medtronic USA, Inc. | $193.97 | 3 | $0 (2020) |
| Egalet US Inc | $174.08 | 22 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $350.77 | 8 | Abbott Laboratories ($281.71) |
| 2023 | $966.08 | 24 | Abbott Laboratories ($800.63) |
| 2022 | $3,875 | 287 | Abbott Laboratories ($3,382) |
| 2021 | $4,105 | 284 | Abbott Laboratories ($3,303) |
| 2020 | $1,870 | 123 | Abbott Laboratories ($1,362) |
| 2019 | $2,172 | 140 | Abbott Laboratories ($1,615) |
| 2018 | $4,403 | 246 | Abbott Laboratories ($3,382) |
| 2017 | $879.23 | 15 | Boston Scientific Corporation ($502.34) |
All Payment Transactions
1,127 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Neuromodulation | ||||||
| 12/03/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: SPINAL HARDWARE | ||||||
| 11/01/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $77.76 | General |
| Category: Neuromodulation | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Neuromodulation | ||||||
| 08/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Neuromodulation | ||||||
| 02/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $52.30 | General |
| Category: Neuromodulation | ||||||
| 01/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $101.36 | General |
| Category: RAPID DIAGNOSTICS | ||||||
| 12/05/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $132.04 | General |
| Category: Neuromodulation | ||||||
| 11/29/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: Neuromodulation | ||||||
| 11/01/2023 | Saluda Medical Americas, Inc. | Evoke SCS (Device) | Food and Beverage | In-kind items and services | $55.28 | General |
| Category: Spinal Cord Stimulation | ||||||
| 10/02/2023 | Saluda Medical Americas, Inc. | Evoke SCS (Device) | Food and Beverage | In-kind items and services | $63.04 | General |
| Category: Spinal Cord Stimulation | ||||||
| 09/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $87.40 | General |
| Category: Neuromodulation | ||||||
| 06/30/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Neuromodulation | ||||||
| 05/25/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Neuromodulation | ||||||
| 05/19/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Neuromodulation | ||||||
| 04/25/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: VACCINES | ||||||
| 04/19/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $150.34 | General |
| Category: Neuromodulation | ||||||
| 04/13/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $121.62 | General |
| Category: Neuromodulation | ||||||
| 04/06/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: VACCINES | ||||||
| 04/05/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Neuromodulation | ||||||
| 04/05/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.99 | General |
| Category: Opioid Analgesic | ||||||
| 03/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Neuromodulation | ||||||
| 03/29/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Neuromodulation | ||||||
| 02/23/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 448 | 690 | $298,569 | $59,415 |
| 2022 | 23 | 1,062 | 2,096 | $1.2M | $180,692 |
| 2021 | 22 | 1,200 | 2,491 | $1.0M | $218,009 |
| 2020 | 29 | 1,548 | 3,069 | $1.4M | $255,779 |
Total Patients
4,258
Total Services
8,346
Medicare Billing
$713,896
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 109 | 162 | $97,200 | $30,323 | 31.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 117 | 175 | $105,000 | $10,539 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 102 | $38,983 | $7,985 | 20.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 17 | 18 | $13,500 | $4,356 | 32.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 20 | 20 | $14,702 | $1,810 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,550 | $1,137 | 20.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 16 | $2,986 | $903.00 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 15 | $4,007 | $900.71 | 22.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 12 | 13 | $10,368 | $730.26 | 7.0% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 14 | 14 | $4,616 | $548.66 | 11.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 29 | 31 | $527.00 | $97.44 | 18.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 113 | $1,130 | $86.28 | 7.6% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 130 | 254 | $153,150 | $48,648 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 368 | $139,656 | $32,805 | 23.5% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 87 | 112 | $84,000 | $26,082 | 31.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 163 | 374 | $224,400 | $22,647 | 10.1% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2022 | 15 | 53 | $352,401 | $12,494 | 3.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 56 | 78 | $57,339 | $7,369 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $15,195 | $3,926 | 25.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 15 | 19 | $23,664 | $3,925 | 16.6% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2022 | 28 | 39 | $31,104 | $3,110 | 10.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 42 | $11,220 | $2,927 | 26.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 32 | 50 | $9,330 | $2,582 | 27.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 11 | 13 | $16,345 | $2,225 | 13.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 22 | 24 | $18,879 | $1,829 | 9.7% |
About Dr. Raphael Ye, DO
Dr. Raphael Ye, DO is a Pain Medicine healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2012. The National Provider Identifier (NPI) number assigned to this provider is 1326314584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raphael Ye, DO has received a total of $18,620 in payments from pharmaceutical and medical device companies, with $350.77 received in 2024. These payments were reported across 1,127 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($18,353).
As a Medicare-enrolled provider, Ye has provided services to 4,258 Medicare beneficiaries, totaling 8,346 services with total Medicare billing of $713,896. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Irving, TX
- Active Since 03/31/2012
- Last Updated 06/02/2023
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326314584
Products in Payments
- Proclaim Family of SCS IPGs (Device) $4,739
- PROCLAIM (Device) $3,277
- Proclaim IPG (Device) $2,770
- OCTRODE (Device) $702.60
- Octrode SCS Leads (Device) $536.95
- SPRIX (Drug) $420.24
- NURTEC ODT (Drug) $417.67
- GENERAL - PAIN MANAGEMENT (Device) $360.84
- SCS IPGs (Device) $353.89
- Prodigy Family of SCS IPGs (Device) $262.99
- LYRICA (Drug) $255.06
- ETERNA (Device) $212.72
- XTAMPZA (Drug) $207.93
- UBRELVY (Drug) $207.23
- DRG IPGs (Device) $197.97
- Swift-Lock SCS (Device) $186.05
- BUNAVAIL 2.1 mg 30-count box (Drug) $174.09
- Penta SCS Leads (Device) $168.62
- Exclaim SCS Leads (Device) $160.90
- 32 CONTACT (Device) $156.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.